Cadila receives tentative USFDA nod for Apremilast tablets
Updated : November 18, 2019 08:22 AM IST
The company has received the tentative approval from the USFDA to market the tablets in the strengths of 10 mg, 20 mg, and 30 mg.
With this, the group now has 276 approvals.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more